Table 1. EGFR CT domain P-site sequences.
P-site | Sequence* | Category** | kcat/KM*** | vphos**** |
992 | DADEYLIPQ | Minor | 74.9 | 8.4 |
1045 | FLQRYSSDP | Minor | - | - |
1068 | PVPEYINQS | Major | 65.4 | 3.3 |
1086 | QNPVYHNQP | Major | 12.1 | 0.3 |
1101 | RDPHYQDPH | - | - | - |
1114 | GNPEYLNTV | Minor | 49.8 | 1.7 |
1148 | DNPDYQQDF | Major | 71.2 | 2.8 |
1173 | ENAEYLRVA | Major | 64.0 | 2.9 |
The sequences surrounding each of the eight tyrosine residues in the EGFR CT domain are shown, with the tyrosine identifying the P-site highlighted in bold.
Qualitative categorization based on the consensus of experiments characterizing major or minor sites of EGFR self-phosphorylation (see Table 2; -, phosphorylation not detected).
Steady state catalytic efficiencies kcat/KM (in units of mM−1 min−1) characterizing the phosphorylation of synthetic peptide substrates containing the P-site sequences by the ligand-activated EGFR as determined by Fan et al. [8] (-, not determined).
Predicted relative initial velocities of P-site self-phosphorylation computed as vphos = k′intra.(kcat/KM), where k′intra is relative frequency of binding site interactions for each P-site (the sums for those in both receiver and activator molecules) in simulations performed in the absence of CT domain electrostatic interactions (see Fig. 9 and Supporting Information, Text S1).